Tech Company Financing Transactions
Landmark Bio Funding Round
Advanced Research Projects Agency for Health (ARPA-H) joined a $18.3 million venture round for Landmark Bio. The funding round closed on 4/1/2026.
Transaction Overview
Company Name
Announced On
4/1/2026
Transaction Type
Venture Equity
Amount
$18,300,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
300 North Beacon Street
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Undisclosed
Website
Email Address
Overview
Landmark Bio, an Artis BioSolutions company, provides integrated capabilities to support the development and scalable manufacturing of advanced therapies and emerging biotechnologies. Operating from its facility in Watertown, Massachusetts, the company combines process development, advanced analytics, and GMP manufacturing to help biotechnology and pharmaceutical partners translate breakthrough science into clinical and commercial reality.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Neel
Chief Scientific Officer
Mike Houston
Chief Technical Officer
Gregg Nyberg
VP - Administration
Leeza Frantz
VP - Bus. Development
Eli Kraus
VP - Bus. Development
Amanda Owens
VP - Bus. Development
Peter Stolba
VP - Bus. Development
Kris Ward
VP - Operations
Olga Mollin
VP - Regulatory Affairs
Michael Sousa
Browse more venture capital transactions:
Prev: 4/1/2026: TippingPoint Biosciences venture capital transaction
Next: 4/1/2026: Manna Air Delivery venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs